Proton Beam Therapy - the Challenges of Delivering High-quality Evidence of Clinical Benefit

被引:17
作者
Amos, R. [1 ]
Bulbeck, H. [2 ]
Burnet, N. G. [3 ,4 ,5 ]
Crellin, A. [6 ]
Eaton, D.
Evans, P. [7 ,8 ]
Hall, E. [9 ]
Hawkins, M. A. [10 ]
Kirkby, K. J. [3 ,4 ]
Mackay, R. [11 ]
Sebag-Montefiore, D. [13 ,14 ]
Sharma, R. [12 ]
机构
[1] UCL, Dept Med Phys & Biomed Engn, Proton & Adv Radiotherapy Grp, London, England
[2] Brainstrust, Cowes, England
[3] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
[4] Christie NHS Fdn Trust, Manchester, Lancs, England
[5] Leeds Teaching Hosp Trust, Leeds Canc Ctr, NHS England Natl Clin Lead Proton Beam Therapy, Leeds, W Yorkshire, England
[6] Mt Vernon Hosp, Natl Radiotherapy Trials Qual Assurance Grp RTTQA, Northwood, Middx, England
[7] Univ Surrey, CVSSP, Guildford, Surrey, England
[8] Natl Phys Lab, Teddington, Middx, England
[9] Inst Canc Res, London, England
[10] Univ Oxford, CRUK MRC Oxford Inst Radiat Oncol, Gray Labs, Oxford, England
[11] Christie NHS Fdn Trust, Christie Med Phys & Engn, Manchester, Lancs, England
[12] UCL Canc Inst, NIHR Univ Coll London Hosp Biomed Res Ctr, London, England
[13] Univ Leeds, Radiotherapy Res Grp, Leeds, W Yorkshire, England
[14] Leeds Canc Ctr, Leeds, W Yorkshire, England
基金
英国工程与自然科学研究理事会; 英国医学研究理事会;
关键词
Proton beam therapy; external beam radiotherapy; clinical trials; INTENSITY-MODULATED RADIOTHERAPY; CANCER; TRIAL;
D O I
10.1016/j.clon.2018.02.031
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The use of proton beam therapy (PBT) offers the opportunity to improve greater conformality of radiotherapy treatment delivery in some patients. However, it is associated with a high capital cost and the need to build new dedicated facilities. We discuss how the global radiotherapy community can respond to the challenge of producing high-quality evidence of clinical benefit from PBT in adult patients. In the UK, the National Cancer Research Institute-funded Clinical and Radiotherapy Translational group has established the PBT Clinical Trial Strategy Group. An eight-point framework is described that can assist the development and delivery of high-quality clinical trials. (C) 2018 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.
引用
收藏
页码:280 / 284
页数:5
相关论文
共 20 条
[1]   Effect of patient choice and hospital competition on service configuration and technology adoption within cancer surgery: a national, population-based study [J].
Aggarwal, Ajay ;
Lewis, Daniel ;
Mason, Malcolm ;
Purushotham, Arnie ;
Sullivan, Richard ;
van der Meulen, Jan .
LANCET ONCOLOGY, 2017, 18 (11) :1445-1453
[2]  
[Anonymous], COCHRANE DATABASE SY
[3]   Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative [J].
Bogaerts, Jan ;
Sydes, Matthew R. ;
Keat, Nicola ;
McConnell, Andrea ;
Benson, Al ;
Ho, Alan ;
Rotha, Arnaud ;
Fortpied, Catherine ;
Eng, Cathy ;
Peckitt, Clare ;
Coens, Corneel ;
Pettaway, Curtis ;
Arnold, Dirk ;
Hall, Emma ;
Marshall, Ernie ;
Sclafani, Francesco ;
Hatcher, Helen ;
Earl, Helena ;
Ray-Coquard, Isabelle ;
Paul, James ;
Blay, Jean-Yves ;
Whelan, Jeremy ;
Panageas, Kathy ;
Wheatley, Keith ;
Harrington, Kevin ;
Licitra, Lisa ;
Billingham, Lucinda ;
Hensley, Martee ;
McCabe, Martin ;
Patel, Poulam M. ;
Carvajal, Richard ;
Wilson, Richard ;
Glynne-Jones, Rob ;
McWilliams, Rob ;
Leyvraz, Serge ;
Rao, Sheela ;
Nicholson, Steve ;
Filiaci, Virginia ;
Negrouk, Anastassia ;
Lacombe, Denis ;
Dupont, Elisabeth ;
Pauporte, Iris ;
Welch, John J. ;
Law, Kate ;
Trimble, Ted ;
Seymour, Matthew .
EUROPEAN JOURNAL OF CANCER, 2015, 51 (03) :271-281
[4]   Methodological Considerations in the Evaluation of Radiotherapy Technologies [J].
Burnet, N. G. ;
Billingham, L. J. ;
Chan, C. S. K. ;
Hall, E. ;
Macdougall, J. ;
Mackay, R. I. ;
Maughan, T. S. ;
Nutting, C. M. ;
Staffurth, J. N. ;
Illidge, T. M. .
CLINICAL ONCOLOGY, 2012, 24 (10) :707-709
[5]   Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial [J].
Dearnaley, David ;
Syndikus, Isabel ;
Mossop, Helen ;
Khoo, Vincent ;
Birtle, Alison ;
Bloomfield, David ;
Graham, John ;
Kirkbride, Peter ;
Logue, John ;
Malik, Zafar ;
Money-Kyrle, Julian ;
O'Sullivan, Joe M. ;
Panades, Miguel ;
Parker, Chris ;
Patterson, Helen ;
Scrase, Christopher ;
Staffurth, John ;
Stockdale, Andrew ;
Tremlett, Jean ;
Bidmead, Margaret ;
Mayles, Helen ;
Naismith, Olivia ;
South, Chris ;
Gao, Annie ;
Cruickshank, Clare ;
Hassan, Shama ;
Pugh, Julia ;
Griffin, Clare ;
Hall, Emma .
LANCET ONCOLOGY, 2016, 17 (08) :1047-1060
[6]   Dosimetric explanations of fatigue in head and neck radiotherapy: An analysis from the PARSPORT Phase III trial [J].
Gulliford, Sarah L. ;
Miah, Aisha B. ;
Brennan, Sinead ;
McQuaid, Dualta ;
Clark, Catharine H. ;
Partridge, Mike ;
Harrington, Kevin J. ;
Morden, James P. ;
Hall, Emma ;
Nutting, Christopher M. .
RADIOTHERAPY AND ONCOLOGY, 2012, 104 (02) :205-212
[7]   Introducing the Cancer Research UK Advanced Radiotherapy Technologies Network (ART-NET) [J].
Harrington, K. ;
Hall, E. ;
Hawkins, M. ;
Henry, A. ;
MacKay, R. ;
Maughan, T. ;
McDonald, A. ;
Nutting, C. ;
Oelfke, U. ;
Sebag-Montefiore, D. ;
Sharma, R. A. ;
van Herk, M. ;
Faivre-Finn, C. .
CLINICAL ONCOLOGY, 2017, 29 (11) :707-710
[8]   Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer The ROLARR Randomized Clinical Trial [J].
Jayne, David ;
Pigazzi, Alessio ;
Marshall, Helen ;
Croft, Julie ;
Corrigan, Neil ;
Copeland, Joanne ;
Quirke, Phil ;
West, Nick ;
Rautio, Tero ;
Thomassen, Niels ;
Tilney, Henry ;
Gudgeon, Mark ;
Bianchi, Paolo Pietro ;
Edlin, Richard ;
Hulme, Claire ;
Brown, Julia .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (16) :1569-1580
[9]   Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach [J].
Langendijk, Johannes A. ;
Lambin, Philippe ;
De Ruysscher, Dirk ;
Widder, Joachim ;
Bos, Mike ;
Verheij, Marcel .
RADIOTHERAPY AND ONCOLOGY, 2013, 107 (03) :267-273
[10]  
Medical Research Council, 2009, DEV EVALUATING COMPL